ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancers

Aritro Nath, Adam L. Cohen, Andrea H. Bild
doi: https://doi.org/10.1101/2021.02.03.21251035

Article Information

doi 
https://doi.org/10.1101/2021.02.03.21251035
History 
  • November 9, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Aritro Nath1,
  2. Adam L. Cohen2 and
  3. Andrea H. Bild1,*
  1. 1Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Institute, Monrovia, California
  2. 2Neuro Oncology Program, Inova Schar Cancer Institute, Fairfax, Virginia
  1. ↵*Correspondence: Andrea H. Bild, Ph.D., Professor, Department of Medical Oncology and Therapeutics City of Hope Comprehensive Cancer Institute, 1218 S Fifth Ave, Monrovia, CA 91016 (626) 218-6052, abild{at}coh.org
Back to top
Posted November 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancers
Aritro Nath, Adam L. Cohen, Andrea H. Bild
medRxiv 2021.02.03.21251035; doi: https://doi.org/10.1101/2021.02.03.21251035
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area